Drug intelligence / Profile preview

LipiGesic M

Development stage
Unknown
Lead developer
PuraMed BioScience
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Sublingual
01

Overview

LipiGesic M is an over-the-counter, homeopathic combination drug formulated as a sublingual (under-the-tongue) gel containing feverfew and ginger. It is designed for the acute treatment of migraine headaches and associated symptoms. The sublingual delivery system allows for rapid absorption directly into the bloodstream, bypassing gastrointestinal breakdown and potentially leading to faster onset of action. Clinical studies have shown that LipiGesic M can reduce or eliminate migraine pain in at least 64% of occurrences, with a favorable safety profile—no serious adverse events or significant drug interactions reported. Its mechanism of action is believed to be related to the anti-inflammatory and vasoprotective effects of its active ingredients, which may inhibit prostaglandin synthesis and modulate vascular tone. Developed by PuraMed BioScience, LipiGesic M has been recognized by headache experts as an excellent first-line therapy for early intervention in acute migraine attacks[1][2][4][5][6].

Brand names
LipiGesic M
Other names
LipiGesic
02

Targets

COXNOS1 (nNOS)

Beyond the preview

Go deeper on LipiGesic M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LipiGesic M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call